TARGET AUDIENCE:

Hematologists, Oncologists, Pharmacists, Physician Assistants, and Advanced Practice Registered Nurses

LEARNING OBJECTIVES:

•    Apply current evidence-based guidelines and clinical trial data to individualize therapy for adult leukemia patients through weekly case reviews and discussions.
•    Integrate current research findings into treatment planning in the inpatient setting.
•    Improve patient outcomes by applying updated treatment algorithms, assessing minimal residual disease (MRD), utilizing geriatric assessment tools, promoting equitable trial access, and eliminating outdated practices.

FACULTY:

Firas El Chaer, M.D.
Chief of Leukemia
Miami Cancer Institute
Baptist Health South Florida 

Yenlys Vega, APRN
Miami Cancer Institute 
Baptist Health South Florida
 

Firas El Chaer, M.D., moderator of this educational activity, receives grant and research support from Amgen, Celgene, SPD Oncology, Sanofi, Bristol Myers Squibb, FibroGen, PharmaEssentia, BioSight, MEI Pharma, Novartis and Arog Pharm. The moderator is also a consultant for SPD Oncology, Amgen, CTI BioPharma, AbbVie, MorphoSys, PharmaEssentia, Bristol Myers Squibb, Geron and Sobi. 

All of the relevant financial relationships listed for this individual have been mitigated.

Yenlys Vega, APRN, moderator of this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the discussion may include off-label or unapproved product usage.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose. 

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 

NONDISCRIMINATION AND CONFIDENTIALITY STATEMENT 

As a participant of the MCI Leukemia Case Review Series involved in the evaluation and improvement of quality of care and service, I recognize that confidentiality is vital. Therefore, I agree to respect and maintain the confidentiality of all discussions, records and information generated in connection within the MCI Leukemia Case Review Series and to make no voluntary disclosure of such information except to persons authorized. As a participant of the MCI Leukemia Case Review Series, I will ensure that my participation in the peer review process and discussions will be made in a non-discriminatory manner and will not be made based on the patients' race, ethnic/national identity, gender, age, sexual orientation, or patient population for which they serve.

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 1 credit hour, CE Broker Course #20-1304509, by the Florida Boards of Medicine, Osteopathic Medicine, and by the Florida Council of Physician Assistants.

This activity has also been approved for 1credit for Nurse Practitioners and Nurses. Baptist Health South Florida CE Broker Provider #50-182.

American Board of Surgery - Maintenance of Certification (MOC) - Accredited CME - General Surgery

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Successful completion of this course is submitted to specialty boards through the ACCME's PARS system.